Resultados de la búsqueda 1661-1670 of 10562 for Holistic Approach

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...

  2. Oncología (médica) - Ensayos clínicos

    This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to, in tissue, discover and validate DNA methylation markers (MDMs) for detection of invasive urothelial carcinoma of the bladder.

  4. Oncología (médica) - Ensayos clínicos

    Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the ...

  5. Oncología (médica) - Ensayos clínicos

    Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.

  6. Oncología (médica) - Ensayos clínicos

    The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab ...

  7. Oncología (médica) - Ensayos clínicos

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to confirm detection of the H3K27M mutation in patient biofluids (CSF, blood, urine, saliva) and uncover the molecular histone ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the establishment of a large tissue ...

  10. Oncología (médica) - Ensayos clínicos

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...